INOVIO Pharmaceuticals Announce 1-For-12 Reverse Stock Split Effective Jan. 24, 2024
Portfolio Pulse from Benzinga Newsdesk
INOVIO Pharmaceuticals has announced a 1-for-12 reverse stock split, set to take effect on January 24, 2024. This action is typically taken by companies to boost the share price to meet exchange listing requirements or to improve perceptions of the stock.

January 23, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
INOVIO Pharmaceuticals' reverse stock split may temporarily increase the stock price due to a reduced number of shares available, but it does not fundamentally change the company's value.
Reverse stock splits are often viewed as a measure to prop up the share price, especially if a company is at risk of delisting due to a low share price. While it may lead to a higher stock price in the short term, it does not change the company's market capitalization or its underlying fundamentals. Investors may have mixed reactions, seeing it either as a positive step towards compliance with exchange listing standards or as a sign of trouble. The long-term impact will depend on the company's performance post-split.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100